Praveen Tyle

Praveen Tyle is a declared insider at 3 companies; the most frequent names are Lexicon Pharmaceuticals, Inc., Bausch & Lomb Inc and Kiora Pharmaceuticals Inc. The record holds 22 filings, for trades running from 19 July 2007 to 19 August 2024.

Every open-market trade on record is a purchase: 1 purchase worth €18k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 8 share grants and 11 option exercises. Since January 2024: 1 purchase and no sales on the market.

The record was last updated on 19 August 2024 with an open-market purchase (€18k) in Kiora Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.